Evidence mapPaperPMID 42267935Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2026

Integrated care for type 1 diabetes: The West Bengal model: 24-month follow-up.

Masuma Yasmin, Pradip Mukhopadhyay, Bobby Paul, Dipta K Mukhopadhyay, Partha S Kar, Graham D Ogle, Sujoy Ghosh, Published on behalf of the Kolkata Type 1 Diabetes Study (K1DS) Group

Abstract readMulticenter Study
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masuma YasminDepartment of Endocrinology and Metabolism, Institute of Post-Graduate Medical Education and Research, Kolkata, India.
Pradip MukhopadhyayDepartment of Endocrinology and Metabolism, Institute of Post-Graduate Medical Education and Research, Kolkata, India.
Bobby PaulDepartment of Preventive and Social Medicine, All India Institute of Hygiene and Public Health, Kolkata, India.
Dipta K MukhopadhyayDepartment of Community Medicine, College of Medicine & Sagore Dutta Hospital, Kolkata, India.
Partha S KarPortsmouth Hospitals, NHS Trust, Cosham, UK.
Graham D OgleLife for a Child Program, Diabetes Australia, New South Wales, Australia.
Sujoy GhoshDepartment of Endocrinology and Metabolism, Institute of Post-Graduate Medical Education and Research, Kolkata, India.
Published on behalf of the Kolkata Type 1 Diabetes Study (K1DS) Group

Funding

Department of Health and Family Welfare, Government of West Bengal
6 · The paper itself

Abstract

aimsThis study aimed to document outcomes of care for individuals with type 1 diabetes (T1D) facilitated by a government-funded model supporting establishment of clinics within secondary-level district hospitals in a lower-middle-income country.

methodsThis prospective, multicentre, single-arm pre-post implementation evaluation study was conducted in government-funded 'model' clinics in district hospitals in West Bengal, India. All consecutive persons with physician-diagnosed T1D (N = 366) were enrolled and immediately transitioned to basal-bolus insulin regimen, with structured monthly follow-up visits. Clinical measures, psychological well-being and diabetes-related expenditures were assessed at baseline, 12 months and 24 months.

resultsAt baseline, median age and age at diagnosis were 15 (10-21) and 8 (5-11) years, respectively, with 41.4% from lower socio-economic class, and most parents/caregivers had not completed primary education. There were no dropouts, with a mean of 23.5 follow-up visits over 24 months. Median glycated haemoglobin (HbA1c) fell from 79 mmol/mol (64-104) [9.4% (8.0-11.7)] at baseline to 72 mmol/mol (58-87) [8.7% (7.5-10.1)] at 12 months, which further fell to 64 mmol/mol (54-73) [8.0% (7.1-8.8)] at 24 months (p < 0.0001). No episodes of documented diabetic ketoacidosis, hospital admissions or deaths occurred. Psychological well-being improved. Median monthly expenditures dropped from 2600 INR (~30 USD) at baseline to 200 INR (~2 USD) at 24 months (p < 0.0001).

conclusionsThis novel public health system-supported model of T1D improved clinical parameters and psychological well-being of those living with T1D and their parents/caregivers and reduced expenditures.

Indexed as

Delivery of Health Care, IntegratedDiabetes Mellitus, Type 1Hypoglycemic AgentsAdolescentChildChild, PreschoolFemaleFollow-Up StudiesGlycated HemoglobinHumansIndiaInsulinMaleProspective StudiesYoung AdultGlycated HemoglobinHypoglycemic AgentsInsulingovernment‐fundedmodel of caretype 1 diabetes

Identifiers

PMID42267935
PMCPMC13380375

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.